遠(yuǎn)程醫(yī)療的初創(chuàng)公司這么多，強(qiáng)生為什么大手筆投資這一家？
Jonathan Vanian
2020-08-25
在新冠疫情期間，遠(yuǎn)程醫(yī)療行業(yè)日益興起，投資者堅(jiān)信即使在疫情結(jié)束之后，這種熱度也會(huì)持續(xù)下去。
最近的例子是一家初創(chuàng)公司Thirty Madison。該公司提供治療脫發(fā)、偏頭痛和胃酸反流的在線醫(yī)療平臺(tái)。該公司在14日宣布，從醫(yī)學(xué)用品巨頭強(qiáng)生（Johnson & Johnson）旗下的風(fēng)險(xiǎn)投資部門以及Polaris Partners（領(lǐng)投本輪融資）、Maveron和Northzone等投資公司融資4,700萬美元。
這是強(qiáng)生旗下的風(fēng)投部門在遠(yuǎn)程醫(yī)療領(lǐng)域的一次大手筆投資。強(qiáng)生北美西部、澳大利亞和新西蘭投資負(fù)責(zé)人斯泰西?費(fèi)爾德在一封電子郵件中表示，投資Thirty Madison“符合我們的整體策略，即提供新型醫(yī)療產(chǎn)品和解決方案，解決人們的迫切需求?！?/p>
她補(bǔ)充說，該筆投資“體現(xiàn)了一個(gè)廣泛趨勢(shì)，即人們正在尋求慢性醫(yī)療的個(gè)性化方案?！贝送?，她表示：“新冠疫情加快了醫(yī)療護(hù)理方式的轉(zhuǎn)變，例如通過遠(yuǎn)程醫(yī)療。”她認(rèn)為這種轉(zhuǎn)變并不是一時(shí)的熱潮。
事實(shí)上，在新冠疫情期間，醫(yī)生和患者都要盡量避免接觸病毒，因此遠(yuǎn)程醫(yī)療服務(wù)大受歡迎。
提供遠(yuǎn)程醫(yī)療服務(wù)的公司，例如2017年成立的Thirty Madison，面臨著Teledoc、MDLive和American Well等公司的激烈競(jìng)爭(zhēng)。許多公司經(jīng)營(yíng)遠(yuǎn)程醫(yī)療服務(wù)的時(shí)間更長(zhǎng)，資金實(shí)力更雄厚。
Thirty Madison公司CEO史蒂文?高騰特格說，該初創(chuàng)公司正在嘗試以個(gè)別慢性疾病為業(yè)務(wù)重點(diǎn)，而不是提供更多通用服務(wù)，例如虛擬就診等，希望以此作為區(qū)別于競(jìng)爭(zhēng)對(duì)手的特色。該公司的服務(wù)支持患者通過特定疾病的門戶網(wǎng)站尋醫(yī)問藥，安排虛擬就診和購(gòu)買藥品等。
Polaris Partners主理合伙人兼Thirty Madison新任董事會(huì)成員埃米?舒爾曼說，在線醫(yī)療服務(wù)早在新冠疫情之前已經(jīng)開始飛速發(fā)展，因?yàn)槟贻p人生活中的很多事情都在網(wǎng)上解決。
舒爾曼曾在制藥業(yè)巨頭輝瑞（Pfizer）經(jīng)營(yíng)消費(fèi)者業(yè)務(wù)。她說：“有一代人將在線上完成各種事情，這在我們這一代人看來是不可思議的?！?/p>
Thirty Madison的收入來自通過網(wǎng)站銷售藥品和治療方法的所得。
高騰特格承認(rèn)，患者可能不選擇公司的醫(yī)療平臺(tái)，改為從其他渠道購(gòu)買藥品。但他說公司提供的一站式醫(yī)療服務(wù)，更能吸引患者。隨著許多人因?yàn)樾鹿谝咔槭状螄L試在線醫(yī)療服務(wù)，他希望他的初創(chuàng)公司的服務(wù)能夠脫穎而出。
高騰特格：“過去三年，我們一直在為這個(gè)時(shí)刻做準(zhǔn)備，而且我們能夠抓住這次良機(jī)?！?
他補(bǔ)充說，目前沒有計(jì)劃授權(quán)公司的技術(shù)，支持其他公司創(chuàng)建醫(yī)療門戶網(wǎng)站。但他對(duì)未來提供這種授權(quán)保持開放的心態(tài)。
Thirty Madison自創(chuàng)立至今共融資7,000萬美元。對(duì)于上一輪融資的估值，公司拒絕發(fā)表評(píng)論。（財(cái)富中文網(wǎng)）
譯者：Biz
在新冠疫情期間，遠(yuǎn)程醫(yī)療行業(yè)日益興起，投資者堅(jiān)信即使在疫情結(jié)束之后，這種熱度也會(huì)持續(xù)下去。
最近的例子是一家初創(chuàng)公司Thirty Madison。該公司提供治療脫發(fā)、偏頭痛和胃酸反流的在線醫(yī)療平臺(tái)。該公司在14日宣布，從醫(yī)學(xué)用品巨頭強(qiáng)生（Johnson & Johnson）旗下的風(fēng)險(xiǎn)投資部門以及Polaris Partners（領(lǐng)投本輪融資）、Maveron和Northzone等投資公司融資4,700萬美元。
這是強(qiáng)生旗下的風(fēng)投部門在遠(yuǎn)程醫(yī)療領(lǐng)域的一次大手筆投資。強(qiáng)生北美西部、澳大利亞和新西蘭投資負(fù)責(zé)人斯泰西?費(fèi)爾德在一封電子郵件中表示，投資Thirty Madison“符合我們的整體策略，即提供新型醫(yī)療產(chǎn)品和解決方案，解決人們的迫切需求。”
她補(bǔ)充說，該筆投資“體現(xiàn)了一個(gè)廣泛趨勢(shì)，即人們正在尋求慢性醫(yī)療的個(gè)性化方案?！贝送?，她表示：“新冠疫情加快了醫(yī)療護(hù)理方式的轉(zhuǎn)變，例如通過遠(yuǎn)程醫(yī)療?！彼J(rèn)為這種轉(zhuǎn)變并不是一時(shí)的熱潮。
事實(shí)上，在新冠疫情期間，醫(yī)生和患者都要盡量避免接觸病毒，因此遠(yuǎn)程醫(yī)療服務(wù)大受歡迎。
提供遠(yuǎn)程醫(yī)療服務(wù)的公司，例如2017年成立的Thirty Madison，面臨著Teledoc、MDLive和American Well等公司的激烈競(jìng)爭(zhēng)。許多公司經(jīng)營(yíng)遠(yuǎn)程醫(yī)療服務(wù)的時(shí)間更長(zhǎng)，資金實(shí)力更雄厚。
Thirty Madison公司CEO史蒂文?高騰特格說，該初創(chuàng)公司正在嘗試以個(gè)別慢性疾病為業(yè)務(wù)重點(diǎn)，而不是提供更多通用服務(wù)，例如虛擬就診等，希望以此作為區(qū)別于競(jìng)爭(zhēng)對(duì)手的特色。該公司的服務(wù)支持患者通過特定疾病的門戶網(wǎng)站尋醫(yī)問藥，安排虛擬就診和購(gòu)買藥品等。
Polaris Partners主理合伙人兼Thirty Madison新任董事會(huì)成員埃米?舒爾曼說，在線醫(yī)療服務(wù)早在新冠疫情之前已經(jīng)開始飛速發(fā)展，因?yàn)槟贻p人生活中的很多事情都在網(wǎng)上解決。
舒爾曼曾在制藥業(yè)巨頭輝瑞（Pfizer）經(jīng)營(yíng)消費(fèi)者業(yè)務(wù)。她說：“有一代人將在線上完成各種事情，這在我們這一代人看來是不可思議的?！?/p>
Thirty Madison的收入來自通過網(wǎng)站銷售藥品和治療方法的所得。
高騰特格承認(rèn)，患者可能不選擇公司的醫(yī)療平臺(tái)，改為從其他渠道購(gòu)買藥品。但他說公司提供的一站式醫(yī)療服務(wù)，更能吸引患者。隨著許多人因?yàn)樾鹿谝咔槭状螄L試在線醫(yī)療服務(wù)，他希望他的初創(chuàng)公司的服務(wù)能夠脫穎而出。
高騰特格：“過去三年，我們一直在為這個(gè)時(shí)刻做準(zhǔn)備，而且我們能夠抓住這次良機(jī)?！?
他補(bǔ)充說，目前沒有計(jì)劃授權(quán)公司的技術(shù)，支持其他公司創(chuàng)建醫(yī)療門戶網(wǎng)站。但他對(duì)未來提供這種授權(quán)保持開放的心態(tài)。
Thirty Madison自創(chuàng)立至今共融資7,000萬美元。對(duì)于上一輪融資的估值，公司拒絕發(fā)表評(píng)論。（財(cái)富中文網(wǎng)）
譯者：Biz
Investors are betting that telemedicine's increased popularity during the coronavirus pandemic will continue after the outbreak is over.
The latest example is Thirty Madison, a startup that offers online health portals for treatment of hair loss, migraines, and acid reflux. It said on Thursday that it had raised $47 million from the venture capital arm of health product giant Johnson & Johnson along with investment firms Polaris Partners (which led the round), Maveron, and Northzone.
The investment marks a major investment in telemedicine by Johnson & Johnson's venture capital arm. Stacy Feld, the Johnson & Johnson investment head of west North America, Australia, and New Zealand, said in an email that the investment into Thirty Madison "aligns to our overall strategy, which is to bring new health care products and solutions to the people who need them most."
She added that the investment "reflects the broader trend of individuals seeking personalized, on-demand solutions for their chronic health care needs." In addition, she said that "COVID-19 has accelerated certain changes in the way health care is delivered, for example, via telemedicine" and that she believes it's not a fad.
Indeed, telehealth services are gaining a huge following during the coronavirus pandemic as both doctors and patients try to limit their exposure to the virus.
Companies offering telehealth services like Thirty Madison, founded in 2017, face a huge amount of competition from services like Teledoc, MDLive, and American Well. Many companies involved have much longer track records and deeper pockets.
Thirty Madison CEO Steven Gutentag said the startup is trying to differentiate itself from rivals by focusing on specific chronic disorders rather than offering more general services, like virtual doctor visits. Its service connects patients through portals for specific ailments with physicians, schedules virtual appointments, and orders their medications.
Amy Schulman, managing partner of Polaris Partners and a new Thirty Madison board member, said that online health services were already gaining momentum before COVID-19 because young adults are used to conducting much of their lives online.
“There’s a generation of people who will do things online that were unthinkable to my generation,” said Schulman, who once ran the consumer business for pharmaceutical giant Pfizer.
Thirty Madison makes money by selling medications and treatments through the site.
Gutentag acknowledged that patients could get their medications from elsewhere rather than his company's health portals. But he said that one-stop for health care services makes its sites more appealing to use. He's hoping that with many people trying online health care services for the first time because of the coronavirus, his startup's services will stand out.
"We've been building toward this moment for the last three years and we’re in a position to capitalize on it," said Gutentag.
He added that there are no current plans to license the startup’s technology so that others can create their own health portals. But he left the door open to doing so in the future.
Overall, Thirty Madison has raised a total of $70 million since its founding. It declined to comment about its valuation in its latest funding round.
財(cái)富中文網(wǎng)所刊載內(nèi)容之知識(shí)產(chǎn)權(quán)為財(cái)富媒體知識(shí)產(chǎn)權(quán)有限公司及/或相關(guān)權(quán)利人專屬所有或持有。未經(jīng)許可，禁止進(jìn)行轉(zhuǎn)載、摘編、復(fù)制及建立鏡像等任何使用。
